| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |